SIX:BSLN

Basilea Pharmaceutica AG · SIX · Healthcare · CHF · FY for 2025

Figures on this page computed 2026-11-08 12:27 UTC

Last close

n/aCHF

Market data

21.6xP/E
Price / Earnings per Share (diluted)
Source
computed
Taken on
2026-11-08
Reported in
CHF
- computed
- Computed from the filing for 2025
24.2%ROIC
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
Source
computed
Taken on
2026-11-08
Reported in
CHF
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
17.3%Net margin
Net Income / Revenue x 100
Source
computed
Taken on
2026-11-08
Reported in
CHF
- Computed from the filing for 2025
- Computed from the filing for 2025
25.5%FCF margin
Free Cash Flow / Revenue x 100
Source
computed
Taken on
2026-11-08
Reported in
CHF
- Computed from the filing for 2025
- Computed from the filing for 2025
0.70Debt/equity
Total Debt / Shareholders' Equity
Source
computed
Taken on
2026-11-08
Reported in
CHF
- Computed from the filing for 2025
- Computed from the filing for 2025
n/aDividend yield
We do not hold this figure for this company, so there is nothing to place.
Source
computed
Taken on
2026-11-08
Reported in
CHF
- computed

Growth is the furthest below its sector's middle: 0.43 against 0.50 on the market's range.

What it pays out: n/aWe do not hold this figure for this company, so there is nothing to place.

Five bars, one line

lens 7 of 9

1.60x

-72.00x

-4.19x

0.51x

n/a

SalesProfitFree cash flowDebtPrice

Each bar against this company's own average; the line is that average.

Computed2025

Market datan/a

Each against its own average

4 of 5 read

Except where said otherwise: Computed from the filing for 2025

Sales1.60x
Its own average over 10 years, 145.7M.
Profit-72.00x
Its own average over 10 years, -558.3K.
Free cash flow-4.19x
Its own average over 10 years, -14.1M.
Debt0.51x
Its own average over 10 years, 176.4M.
Pricen/a
Its own average over 0 years. Market data

Profit is furthest from its own average, at -72.00 times.

Sales is 1.60 times its own 10-year average; Profit is -72.00 times its own 10-year average; Free cash flow is -4.19 times its own 10-year average; Debt is 0.51 times its own 10-year average.

Every figure in this lens

Except where said otherwise: Computed from the filing for 2025

Sales against its own 10-year average1.60
Source
computed
Statement
income
Fiscal year
2025
Reported in
CHF
Profit against its own 10-year average-72.00
Source
computed
Statement
income
Fiscal year
2025
Reported in
CHF
Free cash flow against its own 10-year average-4.19
Source
computed
Statement
income
Fiscal year
2025
Reported in
CHF
Debt against its own 10-year average0.51
Source
computed
Statement
income
Fiscal year
2025
Reported in
CHF
Price against its own 0-year averagen/aMarket data
Not held.
Source
market
Reported in
CHF